A new, healthy liver offers the best survival for patients with early-stage liver cancer. But a new study, led by Katie Ross-Driscoll, Ph.D., MPH, of Regenstrief Institute and Indiana University School of Medicine Department of Surgery, has identified disparities in liver transplant referral and evaluation, which must precede waitlisting, for these potentially lifesaving procedures.

Related Keywords

Georgia , United States , Katherine Ross Driscoll , Rachel Patzer , Katie Ross Driscoll , Regenstrief Institute , Cancer Research Communications , Indiana University School , Medicine Department , Liver Transplant Referral , Hepatocellular Carcinoma , Cancer Research ,